Skip to content

Study Details

ABX464: A Study Drug for People with Active Ulcerative Colitis

(IRB#: IRB_00164026)

Active Ulcerative Colitis is a bowel disease that can cause severe stomach pain and other serious health issues. ABX464 is s study drug for people with this condition. Research is needed to learn the safety and effectiveness of ABX464. The information we gain may aid future patients.

I AM INTERESTED

  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18 years and older
  • Diagnosis and active ulcerative colitis
  • Do not respond to certain medications
  • Participants must use specific birth control
  • In person at the University of Utah

Exclusion Criteria

  • History of colon cancer
  • Recent or planned bowel surgery
  • History or active specific diseases such as heart disease and tuberculosis
  • Infections such as hepatitis B, C, and HIV
  • Drug or alcohol abuse

Will I be paid for my time?

Yes

For more information contact:

Julie Will

julie.will@hsc.utah.edu

  801-581-7802

IRB#: IRB_00164026

PI: John Valentine

Department: GASTROENTEROLOGY

Approval Date: 2023-07-12 06:00:00

Specialties: Gastroenterology

Last Updated: 6/8/23